Exelixis
EXEL
#1318
Rank
โ‚ฌ15.13 B
Marketcap
62,02ย โ‚ฌ
Share price
-0.31%
Change (1 day)
68.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: 66,07ย โ‚ฌ Euro on 2026-11-04

Lowest end of day price: 1,17ย โ‚ฌ Euro on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 55.81%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
247,67ย โ‚ฌ-2.15%๐Ÿ‡บ๐Ÿ‡ธ USA
25,48ย โ‚ฌ-1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
403,14ย โ‚ฌ-3.07%๐Ÿ‡บ๐Ÿ‡ธ USA
42,79ย โ‚ฌ-0.86%๐Ÿ‡ซ๐Ÿ‡ท France
125,13ย โ‚ฌ-3.90%๐Ÿ‡บ๐Ÿ‡ธ USA
54,09ย โ‚ฌ-2.92%๐Ÿ‡บ๐Ÿ‡ธ USA
44,12ย โ‚ฌ-1.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
0,56ย โ‚ฌ 13.38%๐Ÿ‡บ๐Ÿ‡ธ USA
13,62ย โ‚ฌ 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA